Rosuvastatin/Ezetimibe tablets are also approved in 28 countries worldwide. Althera makes the product available to patients in these markets through local and regional partnerships.
US healthcare professionals can read full Prescribing information at roszet.com
Ezetimibe/Atorvastatin tablets are currently approved in the United States and in several European countries. We anticipate the product to be made available to patients during calendar year 2022/23.